Abstract
: Till date for covid 19 infection no specific drug has been developed. This study was taken up to see the effect of remdesevir in moderate and severe covid cases. 22 diagnosed patients of covid 19 in moderate and severe category were included in the study and divived in two groups of 11 patients each. Group a received only symptomatic treatment and other group B received injection remdesevir for 5 days along with symptomatic treatment. : Total 13 male (7 in group A; 6 in group B) and 9 female (4 in group A; 5 in group A) patients were included in the study. Patients in group B receiving injection remdesevir had shortened hospital stay, early symptom improvement and less mortality than those receiving only symptomatic treatment. : With no definite drug till date we conclude that remdesevir could be used as a good alternative treatment in moderate and severe category patients of covid 19.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
